Reply to: Reconciling differences in impact of molecular subtyping on response to cisplatin-based chemotherapy

• Ann Taber,
• Emil Christensen,
• Philippe Lamy,
• Mads Agerbæk,
• Jørgen Bjerggaard Jensen,
• Lars Dyrskjøt

Affiliations

Ann Taber

Department of Molecular Medicine, Aarhus University Hospital

Emil Christensen

Department of Molecular Medicine, Aarhus University Hospital

Philippe Lamy

Department of Molecular Medicine, Aarhus University Hospital

Mads Agerbæk

Department of Oncology, Aarhus University Hospital

Jørgen Bjerggaard Jensen

Department of Clinical Medicine, Aarhus University

Lars Dyrskjøt

Department of Molecular Medicine, Aarhus University Hospital